Home » Science and Research Articles » Can Ozbal, to present at GTCbio's 3rd Assay Development & Screening Technologies Conference
Can Ozbal, to present at GTCbio's 3rd Assay Development & Screening Technologies Conference
. Dr. Ozbal will be speaking on label-free HTS of intractable targets with rapid-fire mass spectrometry
/Science and Research PR News/ - MONROVIA, CA - April 23, 2008 - Dr. Can "Jon" Ozbal, Vice President and General Manager of Rapid Fire Products at BioTrove will be giving a presentation at GTCbio's 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Ozbal will be speaking on label-free HTS of intractable targets with rapid-fire mass spectrometry.
Small molecule high-throughput screening in drug discovery today is dominated by techniques which are dependent upon artificial labels or reporter systems. While effective, these approaches can be affected by certain experimental limitations, such as conformational restrictions imposed by the selected label or compound fluorescence/quenching. Label-free approaches potentially address many of these issues by allowing researchers to investigate more native systems without fluorescence- or luminescence-based readouts. However, due to throughput and expense constraints, label-free methods have been largely relegated to a supporting role as the basis of secondary assays. In this talk a novel mass spectrometry-based approach using the RapidFire high-throughput mass spectrometry system will be described and examples provided. Mass spectrometry-based approaches facilitate rapid assay development since designing and validating assays with surrogate substrates is not necessary. Additionally, mass spectrometry does not suffer from artifacts such as compound auto-fluorescence or quenching and facilitates the screening of many enzymatic reactions for which label-dependent formats are unavailable.
GTCbio's 3rd Assay Development and Screening Technologies conference will provide attendees with critical information to utilize in the discovery and development of assays, while keeping them informed about the latest screening technologies for both high-throughput screening and high-content screening. Topics being covered include cell based assays, high throughput screening, high content screening, in vitro assays and screening, novel assay and screening technologies, and target validation. For more information visit www.gtcbio.com.
ABOUT GTCbio
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Rania Hafez
GTCbio
Marketing Director
434 W. Foothill Blvd.
Monrovia, CA
USA 91106
Voice: 626-256-6405
Fax: 626-256-6460
Website: Visit Our Website |
|
|
|
|
| SCIENCE AND RESEARCH ARCHIVE SEARCH |
|
|
| |
| SUBMIT SCIENCE AND RESEARCH NEWS |
|
|
| |
|
|
Advertise With Us |
About Us |
Contact Us